89bio Inc. (ETNB) NASDAQ
$8.58 (0.34) (-3.81%)
Market Cap: $849.40M
As of 04/24/24 04:00 PM EDT. Market closed.
89bio Inc. (ETNB)
NASDAQ
$8.58
(0.34) (-3.81%)
Market Cap: $849.40M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
89bio, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. its lead product candidate is bio89-100, a glycopegylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. the company also intends to develop bio89-100 for the treatment of severe ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
45
URL
Address
.
PRICE CHART FOR 89BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.26
Previous Close
$8.92
Days Range
$8.92 - $9.55
52 week range
$6.58 - $22.93
Volume
871,176
Avg. Volume (30 days)
787,746
Market Cap
$849.40M
Dividend Yield
-
P/E
-
Shares Outstanding
95,224,724
Open
$9.26
Previous Close
$8.92
Days Range
$8.92 - $9.55
52 week range
$6.58 - $22.93
Volume
871,176
Avg. Volume (30 days)
787,746
Market Cap
$849.40M
Dividend Yield
-
P/E
-
Shares Outstanding
95,224,724
FINANCIAL STATEMENTS FOR 89BIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR 89BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Apr 11, 2024 | Option Exercise | $5.32 | 1,408,450 | 7,499,996 | 13,840,034 | Apr 15, 2024, 04:15 PM |
| PALEKAR ROHAN | Chief Executive Officer | Apr 01, 2024 | Option Exercise | $1.93 | 25,000 | 48,250 | 511,889 | Apr 03, 2024, 04:01 PM |
| PALEKAR ROHAN | Chief Executive Officer | Apr 01, 2024 | Sale | $10.91 | 52,718 | 575,153 | 459,171 | Apr 03, 2024, 04:01 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 04, 2024 | Buy | $15.35 | 1,350,000 | 20,722,501 | 12,431,584 | Mar 06, 2024, 05:40 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 26, 2024 | Sale | $10.76 | 4,477 | 48,173 | 486,889 | Feb 28, 2024, 06:43 PM |
| Martins Ryan | Chief Financial Officer | Feb 17, 2024 | Option Exercise | $9.74 | 778 | 7,578 | 106,609 | Feb 23, 2024, 08:55 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 17, 2024 | Option Exercise | $9.74 | 4,602 | 44,823 | 491,366 | Feb 23, 2024, 08:51 PM |
| Le-Nguyen Quoc | See Remarks | Feb 17, 2024 | Option Exercise | $9.74 | 1,046 | 10,188 | 222,149 | Feb 23, 2024, 08:50 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 17, 2024 | Option Exercise | $9.74 | 1,046 | 10,188 | 158,437 | Feb 23, 2024, 08:41 PM |
| Martins Ryan | Chief Financial Officer | Feb 09, 2024 | Option Exercise | $8.45 | 3,568 | 30,150 | 107,387 | Feb 13, 2024, 09:12 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $8.45 | 3,568 | 30,150 | 159,483 | Feb 13, 2024, 09:04 PM |
| Le-Nguyen Quoc | See Remarks | Feb 09, 2024 | Option Exercise | $8.45 | 3,568 | 30,150 | 223,195 | Feb 13, 2024, 09:02 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 09, 2024 | Option Exercise | $8.45 | 12,670 | 107,061 | 480,968 | Feb 13, 2024, 08:58 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2024 | Option Exercise | $9.80 | 1,190 | 11,662 | 163,051 | Feb 05, 2024, 08:22 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2024 | Option Exercise | $9.80 | 1,190 | 11,662 | 226,763 | Feb 05, 2024, 08:22 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2024 | Option Exercise | $9.80 | 5,068 | 49,666 | 493,646 | Feb 05, 2024, 08:16 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2024 | Option Exercise | $9.80 | 892 | 8,742 | 110,955 | Feb 05, 2024, 08:07 PM |
| Mansbach Harry H | Chief Medical Officer | Jan 05, 2024 | Option Exercise | $11.53 | 9,671 | 111,507 | 115,491 | Jan 08, 2024, 07:00 PM |
| Martins Ryan | Chief Financial Officer | Jan 05, 2024 | Option Exercise | $11.53 | 6,124 | 70,610 | 63,097 | Jan 08, 2024, 06:35 PM |
| Le-Nguyen Quoc | See Remarks | Jan 05, 2024 | Option Exercise | $11.53 | 9,671 | 111,507 | 179,203 | Jan 08, 2024, 06:32 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 05, 2024 | Option Exercise | $11.53 | 27,511 | 317,202 | 348,714 | Jan 08, 2024, 06:31 PM |
| PALEKAR ROHAN | Chief Executive Officer | Dec 29, 2023 | Option Exercise | $1.93 | 50,000 | 96,500 | 351,225 | Jan 03, 2024, 04:54 PM |
| PALEKAR ROHAN | Chief Executive Officer | Dec 29, 2023 | Sale | $11.20 | 50,000 | 560,000 | 301,225 | Jan 03, 2024, 04:54 PM |
| Mansbach Harry H | Chief Medical Officer | Sep 09, 2023 | Option Exercise | $16.61 | 3,821 | 63,467 | 100,162 | Sep 12, 2023, 04:06 PM |
| Martins Ryan | Chief Financial Officer | Sep 09, 2023 | Option Exercise | $16.61 | 2,074 | 34,449 | 54,221 | Sep 12, 2023, 04:05 PM |
| Le-Nguyen Quoc | See Remarks | Sep 09, 2023 | Option Exercise | $16.61 | 4,958 | 82,352 | 163,874 | Sep 12, 2023, 04:05 PM |
| Mansbach Harry H | Chief Medical Officer | Aug 17, 2023 | Option Exercise | $15.46 | 1,014 | 15,676 | 103,983 | Aug 21, 2023, 05:51 PM |
| Mansbach Harry H | Chief Medical Officer | Aug 01, 2023 | Option Exercise | $15.64 | 577 | 9,024 | 104,997 | Aug 21, 2023, 05:51 PM |
| PALEKAR ROHAN | Chief Executive Officer | Aug 17, 2023 | Option Exercise | $15.46 | 4,501 | 69,585 | 300,950 | Aug 21, 2023, 05:49 PM |
| Martins Ryan | Chief Financial Officer | Aug 17, 2023 | Option Exercise | $15.46 | 753 | 11,641 | 56,295 | Aug 21, 2023, 05:45 PM |
| Martins Ryan | Chief Financial Officer | Aug 01, 2023 | Option Exercise | $15.64 | 346 | 5,411 | 57,048 | Aug 21, 2023, 05:45 PM |
| Le-Nguyen Quoc | See Remarks | Aug 01, 2023 | Option Exercise | $15.53 | 1,591 | 24,701 | 169,846 | Aug 21, 2023, 05:43 PM |
| LAPORTE KATHLEEN | Director | Jul 17, 2023 | Option Exercise | $2.64 | 12,500 | 33,000 | 12,500 | Jul 18, 2023, 06:04 PM |
| LAPORTE KATHLEEN | Director | Jul 17, 2023 | Sale | $18.80 | 12,500 | 235,000 | 0 | Jul 18, 2023, 06:04 PM |
| Mansbach Harry H | Chief Medical Officer | Jun 30, 2023 | Option Exercise | $18.95 | 2,882 | 54,614 | 105,574 | Jul 05, 2023, 08:54 PM |
| Le-Nguyen Quoc | See Remarks | Jun 30, 2023 | Option Exercise | $18.95 | 2,882 | 54,614 | 170,423 | Jul 05, 2023, 08:43 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jun 30, 2023 | Option Exercise | $18.95 | 16,527 | 313,187 | 305,451 | Jul 05, 2023, 08:39 PM |
| Martins Ryan | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $18.95 | 2,018 | 38,241 | 57,394 | Jul 05, 2023, 08:36 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jun 05, 2023 | Option Exercise | $1.93 | 15,000 | 28,950 | 301,978 | Jun 07, 2023, 05:04 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jun 05, 2023 | Sale | $20.00 | 15,000 | 300,000 | 286,978 | Jun 07, 2023, 05:04 PM |
| Atkinson Edward Morrow III | Director | Jun 01, 2023 | Option Exercise | $2.61 | 6,250 | 16,312 | 6,250 | Jun 05, 2023, 05:03 PM |
| Atkinson Edward Morrow III | Director | Jun 01, 2023 | Sale | $17.91 | 6,250 | 111,937 | 0 | Jun 05, 2023, 05:03 PM |
| Le-Nguyen Quoc | See Remarks | May 09, 2023 | Option Exercise | $3.11 | 79,571 | 247,466 | 178,654 | May 11, 2023, 05:01 PM |
| Le-Nguyen Quoc | See Remarks | May 09, 2023 | Sale | $18.11 | 13,683 | 247,799 | 164,971 | May 11, 2023, 05:01 PM |
| Martins Ryan | Chief Financial Officer | Apr 04, 2023 | Sale | $14.95 | 8,721 | 130,379 | 53,578 | Apr 06, 2023, 04:06 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 24, 2023 | Buy | $16.25 | 2,461,538 | 39,999,993 | 11,081,584 | Mar 30, 2023, 05:00 PM |
| Hayden Michael R | Director | Apr 07, 2022 | Buy | $3.47 | 10,000 | 34,750 | 93,978 | Mar 30, 2023, 04:26 PM |
| Hayden Michael R | Director | Mar 30, 2022 | Buy | $3.62 | 6,250 | 22,625 | 83,978 | Mar 30, 2023, 04:26 PM |
| Hayden Michael R | Director | Mar 28, 2023 | Buy | $16.15 | 61,538 | 993,839 | 61,538 | Mar 30, 2023, 04:26 PM |
| Hayden Michael R | Director | Apr 25, 2022 | Buy | $2.67 | 10,000 | 26,700 | 103,978 | Mar 30, 2023, 04:26 PM |
| Martins Ryan | Chief Financial Officer | Mar 23, 2023 | Sale | $16.11 | 5,000 | 80,550 | 53,578 | Mar 27, 2023, 07:20 PM |
| PALEKAR ROHAN | Chief Executive Officer | Mar 23, 2023 | Sale | $16.00 | 15,000 | 240,000 | 269,080 | Mar 27, 2023, 07:18 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 17, 2023 | Option Exercise | $13.97 | 2,127 | 29,714 | 94,671 | Feb 22, 2023, 06:41 PM |
| Martins Ryan | Chief Financial Officer | Feb 17, 2023 | Option Exercise | $13.97 | 1,750 | 24,448 | 61,118 | Feb 22, 2023, 06:39 PM |
| Martins Ryan | Chief Financial Officer | Feb 21, 2023 | Sale | $13.89 | 2,540 | 35,281 | 58,578 | Feb 22, 2023, 06:39 PM |
| Le-Nguyen Quoc | See Remarks | Feb 17, 2023 | Option Exercise | $13.97 | 2,140 | 29,896 | 91,179 | Feb 22, 2023, 06:39 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 17, 2023 | Option Exercise | $13.97 | 6,279 | 87,718 | 284,072 | Feb 22, 2023, 06:38 PM |
| Martins Ryan | Chief Financial Officer | Feb 08, 2023 | Sale | $14.41 | 1,480 | 21,327 | 32,868 | Feb 10, 2023, 05:32 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2023 | Option Exercise | $13.24 | 1,360 | 18,006 | 66,798 | Feb 07, 2023, 07:38 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2023 | Option Exercise | $13.24 | 4,078 | 53,993 | 215,351 | Feb 07, 2023, 07:36 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2023 | Option Exercise | $13.24 | 592 | 7,838 | 34,348 | Feb 07, 2023, 07:36 PM |
| Martins Ryan | Chief Financial Officer | Feb 03, 2023 | Option Exercise | $3.11 | 3,000 | 9,330 | 38,960 | Feb 07, 2023, 07:36 PM |
| Martins Ryan | Chief Financial Officer | Feb 03, 2023 | Sale | $13.04 | 3,592 | 46,848 | 38,960 | Feb 07, 2023, 07:36 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2023 | Option Exercise | $13.24 | 1,390 | 18,404 | 63,319 | Feb 07, 2023, 07:35 PM |
| Martins Ryan | Chief Financial Officer | Feb 01, 2023 | Option Exercise | $12.05 | 408 | 4,916 | 35,960 | Feb 03, 2023, 05:10 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 01, 2023 | Option Exercise | $12.05 | 680 | 8,194 | 68,158 | Feb 03, 2023, 05:10 PM |
| Le-Nguyen Quoc | See Remarks | Feb 01, 2023 | Option Exercise | $12.05 | 695 | 8,375 | 64,709 | Feb 03, 2023, 05:08 PM |
| Martins Ryan | Chief Financial Officer | Jan 03, 2023 | Sale | $12.51 | 5,947 | 74,397 | 36,368 | Jan 05, 2023, 06:03 PM |
| Mansbach Harry H | Chief Medical Officer | Nov 15, 2022 | Option Exercise | $9.79 | 3,113 | 30,476 | 68,838 | Dec 13, 2022, 05:52 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Oct 18, 2022 | Buy | $7.65 | 1,172,741 | 8,971,469 | 8,955,410 | Oct 20, 2022, 05:28 PM |
| Le-Nguyen Quoc | See Remarks | Sep 30, 2022 | Option Exercise | $5.79 | 1,297 | 7,510 | 65,404 | Sep 30, 2022, 07:06 PM |
| Le-Nguyen Quoc | See Remarks | Sep 28, 2022 | Option Exercise | $5.76 | 2,882 | 16,600 | 62,951 | Sep 30, 2022, 07:06 PM |
| Martins Ryan | Chief Financial Officer | Sep 28, 2022 | Option Exercise | $5.76 | 2,018 | 11,624 | 42,315 | Sep 30, 2022, 07:05 PM |
| Mansbach Harry H | Chief Medical Officer | Sep 28, 2022 | Option Exercise | $5.76 | 2,882 | 16,600 | 62,951 | Sep 30, 2022, 07:04 PM |
| PALEKAR ROHAN | Chief Executive Officer | Sep 28, 2022 | Option Exercise | $5.76 | 11,527 | 66,396 | 219,429 | Sep 30, 2022, 07:02 PM |
| PALEKAR ROHAN | Chief Executive Officer | Sep 08, 2022 | Option Exercise | $1.93 | 100,000 | 193,000 | 197,623 | Sep 09, 2022, 04:39 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 01, 2022 | Buy | $3.55 | 2,816,900 | 9,999,995 | 7,782,669 | Jul 06, 2022, 05:27 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,022 | 5,345 | 22,478 | Apr 13, 2022, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2022 | Option Exercise | $5.23 | 4,088 | 21,380 | 95,957 | Apr 13, 2022, 04:05 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
| Waisbourd Ram | See Remarks | Feb 01, 2022 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 03, 2022, 04:30 PM |
| Waisbourd Ram | See Remarks | Feb 01, 2022 | Sale | $5.70 | 7,000 | 39,900 | 0 | Feb 03, 2022, 04:30 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 28, 2022 | Buy | $6.14 | 2,500 | 15,350 | 45,845 | Jan 31, 2022, 04:30 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 27, 2022 | Buy | $7.50 | 5,000 | 37,500 | 43,345 | Jan 31, 2022, 04:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 26, 2022 | Sale | $8.38 | 21,482 | 180,019 | 1,829,436 | Jan 27, 2022, 05:22 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 25, 2022 | Sale | $8.40 | 49,091 | 412,364 | 1,840,176 | Jan 27, 2022, 05:22 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2021 | Sale | $11.48 | 7,000 | 80,360 | 0 | Dec 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Nov 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2021, 06:37 PM |
| Waisbourd Ram | See Remarks | Nov 16, 2021 | Sale | $16.49 | 7,000 | 115,430 | 0 | Nov 18, 2021, 06:37 PM |
| Waisbourd Ram | See Remarks | Oct 18, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Oct 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Oct 18, 2021 | Sale | $17.49 | 7,000 | 122,430 | 0 | Oct 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Sep 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Sep 20, 2021, 04:32 PM |
| Waisbourd Ram | See Remarks | Sep 16, 2021 | Sale | $19.46 | 7,000 | 136,220 | 0 | Sep 20, 2021, 04:32 PM |
| Waisbourd Ram | See Remarks | Aug 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Aug 18, 2021, 04:10 PM |
| Waisbourd Ram | See Remarks | Aug 16, 2021 | Sale | $18.28 | 7,000 | 127,960 | 0 | Aug 18, 2021, 04:10 PM |
| Waisbourd Ram | See Remarks | Jul 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jul 19, 2021, 04:05 PM |
| Waisbourd Ram | See Remarks | Jul 16, 2021 | Sale | $16.80 | 7,000 | 117,600 | 0 | Jul 19, 2021, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jul 07, 2021 | Buy | $17.07 | 5,000 | 85,350 | 35,000 | Jul 08, 2021, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jul 08, 2021 | Buy | $16.25 | 2,000 | 32,500 | 37,000 | Jul 08, 2021, 04:05 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jun 02, 2021 | Buy | $18.77 | 22,138 | 415,530 | 4,965,769 | Jun 04, 2021, 04:31 PM |
| Grunberg Gregory | Director | Apr 21, 2021 | Sale | $27.60 | 850 | 23,460 | 0 | Apr 23, 2021, 05:27 PM |
| Waisbourd Ram | See Remarks | Mar 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Mar 17, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Mar 16, 2021 | Sale | $24.20 | 7,000 | 169,400 | 0 | Mar 17, 2021, 04:30 PM |
| Hayden Michael R | Director | Feb 23, 2021 | Option Exercise | $2.13 | 80,904 | 172,236 | 80,904 | Feb 25, 2021, 05:01 PM |
| Waisbourd Ram | See Remarks | Feb 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 17, 2021, 04:22 PM |
| Waisbourd Ram | See Remarks | Feb 16, 2021 | Sale | $23.39 | 7,000 | 163,730 | 0 | Feb 17, 2021, 04:22 PM |
| Waisbourd Ram | See Remarks | Jan 19, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jan 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Jan 19, 2021 | Sale | $21.16 | 7,000 | 148,120 | 0 | Jan 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 18, 2020, 05:00 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2020 | Sale | $27.04 | 7,000 | 189,280 | 0 | Dec 18, 2020, 05:00 PM |
| Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Option Exercise | $3.11 | 4,548 | 14,144 | 4,548 | Nov 18, 2020, 04:00 PM |
| Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Sale | $28.11 | 4,548 | 127,844 | 0 | Nov 18, 2020, 04:00 PM |
| Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2020, 04:00 PM |
| Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Sale | $27.39 | 7,000 | 191,730 | 0 | Nov 18, 2020, 04:00 PM |
| ORBIMED ADVISORS LLC | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:09 PM |
| Naschitz Anat | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:04 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Sep 17, 2020 | Buy | $28.00 | 1,300,000 | 36,400,000 | 4,736,214 | Sep 21, 2020, 04:30 PM |
| Longitude Capital Partners III, LLC | 10% Owner | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:11 PM |
| Grunberg Gregory | Director | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:08 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 08, 2020 | Buy | $27.50 | 275,000 | 7,562,500 | 3,436,214 | Jul 10, 2020, 04:32 PM |
| Kariv Tomer | Director | Nov 11, 2019 | Buy | $16.00 | 250,000 | 4,000,000 | 250,000 | Nov 13, 2019, 07:10 PM |
| Naschitz Anat | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:07 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Nov 11, 2019 | Buy | $16.00 | 1,500,000 | 24,000,000 | 1,500,000 | Nov 13, 2019, 07:06 PM |
| Grunberg Gregory | Director | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:04 PM |
| Hayden Michael R | Director | Nov 11, 2019 | Buy | $16.00 | 18,750 | 300,000 | 18,750 | Nov 13, 2019, 07:02 PM |
| Longitude Capital Partners III, LLC | 10% Owner | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:02 PM |
| ORBIMED ADVISORS LLC | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| RA CAPITAL MANAGEMENT, L.P. | Director | 04/11/2024 | 7,499,996 |
| PALEKAR ROHAN | Chief Executive Officer | 04/01/2024 | 48,250 |
| PALEKAR ROHAN | Chief Executive Officer | 04/01/2024 | 575,153 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/04/2024 | 20,722,501 |
| PALEKAR ROHAN | Chief Executive Officer | 02/26/2024 | 48,173 |
| Martins Ryan | Chief Financial Officer | 02/17/2024 | 7,578 |
| PALEKAR ROHAN | Chief Executive Officer | 02/17/2024 | 44,823 |
| Le-Nguyen Quoc | See Remarks | 02/17/2024 | 10,188 |
| Mansbach Harry H | Chief Medical Officer | 02/17/2024 | 10,188 |
| Martins Ryan | Chief Financial Officer | 02/09/2024 | 30,150 |
| Mansbach Harry H | Chief Medical Officer | 02/09/2024 | 30,150 |
| Le-Nguyen Quoc | See Remarks | 02/09/2024 | 30,150 |
| PALEKAR ROHAN | Chief Executive Officer | 02/09/2024 | 107,061 |
| Mansbach Harry H | Chief Medical Officer | 02/05/2024 | 11,662 |
| Le-Nguyen Quoc | See Remarks | 02/05/2024 | 11,662 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2024 | 49,666 |
| Martins Ryan | Chief Financial Officer | 02/05/2024 | 8,742 |
| Mansbach Harry H | Chief Medical Officer | 01/05/2024 | 111,507 |
| Martins Ryan | Chief Financial Officer | 01/05/2024 | 70,610 |
| Le-Nguyen Quoc | See Remarks | 01/05/2024 | 111,507 |
| PALEKAR ROHAN | Chief Executive Officer | 01/05/2024 | 317,202 |
| PALEKAR ROHAN | Chief Executive Officer | 12/29/2023 | 96,500 |
| PALEKAR ROHAN | Chief Executive Officer | 12/29/2023 | 560,000 |
| Mansbach Harry H | Chief Medical Officer | 09/09/2023 | 63,467 |
| Martins Ryan | Chief Financial Officer | 09/09/2023 | 34,449 |
| Le-Nguyen Quoc | See Remarks | 09/09/2023 | 82,352 |
| Mansbach Harry H | Chief Medical Officer | 08/17/2023 | 15,676 |
| Mansbach Harry H | Chief Medical Officer | 08/01/2023 | 9,024 |
| PALEKAR ROHAN | Chief Executive Officer | 08/17/2023 | 69,585 |
| Martins Ryan | Chief Financial Officer | 08/17/2023 | 11,641 |
| Martins Ryan | Chief Financial Officer | 08/01/2023 | 5,411 |
| Le-Nguyen Quoc | See Remarks | 08/01/2023 | 24,701 |
| LAPORTE KATHLEEN | Director | 07/17/2023 | 33,000 |
| LAPORTE KATHLEEN | Director | 07/17/2023 | 235,000 |
| Mansbach Harry H | Chief Medical Officer | 06/30/2023 | 54,614 |
| Le-Nguyen Quoc | See Remarks | 06/30/2023 | 54,614 |
| PALEKAR ROHAN | Chief Executive Officer | 06/30/2023 | 313,187 |
| Martins Ryan | Chief Financial Officer | 06/30/2023 | 38,241 |
| PALEKAR ROHAN | Chief Executive Officer | 06/05/2023 | 28,950 |
| PALEKAR ROHAN | Chief Executive Officer | 06/05/2023 | 300,000 |
| Atkinson Edward Morrow III | Director | 06/01/2023 | 16,312 |
| Atkinson Edward Morrow III | Director | 06/01/2023 | 111,937 |
| Le-Nguyen Quoc | See Remarks | 05/09/2023 | 247,466 |
| Le-Nguyen Quoc | See Remarks | 05/09/2023 | 247,799 |
| Martins Ryan | Chief Financial Officer | 04/04/2023 | 130,379 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/24/2023 | 39,999,993 |
| Hayden Michael R | Director | 04/07/2022 | 34,750 |
| Hayden Michael R | Director | 03/30/2022 | 22,625 |
| Hayden Michael R | Director | 03/28/2023 | 993,839 |
| Hayden Michael R | Director | 04/25/2022 | 26,700 |
| Martins Ryan | Chief Financial Officer | 03/23/2023 | 80,550 |
| PALEKAR ROHAN | Chief Executive Officer | 03/23/2023 | 240,000 |
| Mansbach Harry H | Chief Medical Officer | 02/17/2023 | 29,714 |
| Martins Ryan | Chief Financial Officer | 02/17/2023 | 24,448 |
| Martins Ryan | Chief Financial Officer | 02/21/2023 | 35,281 |
| Le-Nguyen Quoc | See Remarks | 02/17/2023 | 29,896 |
| PALEKAR ROHAN | Chief Executive Officer | 02/17/2023 | 87,718 |
| Martins Ryan | Chief Financial Officer | 02/08/2023 | 21,327 |
| Mansbach Harry H | Chief Medical Officer | 02/05/2023 | 18,006 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2023 | 53,993 |
| Martins Ryan | Chief Financial Officer | 02/05/2023 | 7,838 |
| Martins Ryan | Chief Financial Officer | 02/03/2023 | 9,330 |
| Martins Ryan | Chief Financial Officer | 02/03/2023 | 46,848 |
| Le-Nguyen Quoc | See Remarks | 02/05/2023 | 18,404 |
| Martins Ryan | Chief Financial Officer | 02/01/2023 | 4,916 |
| Mansbach Harry H | Chief Medical Officer | 02/01/2023 | 8,194 |
| Le-Nguyen Quoc | See Remarks | 02/01/2023 | 8,375 |
| Martins Ryan | Chief Financial Officer | 01/03/2023 | 74,397 |
| Mansbach Harry H | Chief Medical Officer | 11/15/2022 | 30,476 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 10/18/2022 | 8,971,469 |
| Le-Nguyen Quoc | See Remarks | 09/30/2022 | 7,510 |
| Le-Nguyen Quoc | See Remarks | 09/28/2022 | 16,600 |
| Martins Ryan | Chief Financial Officer | 09/28/2022 | 11,624 |
| Mansbach Harry H | Chief Medical Officer | 09/28/2022 | 16,600 |
| PALEKAR ROHAN | Chief Executive Officer | 09/28/2022 | 66,396 |
| PALEKAR ROHAN | Chief Executive Officer | 09/08/2022 | 193,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/01/2022 | 9,999,995 |
| Mansbach Harry H | Chief Medical Officer | 02/05/2022 | 7,128 |
| Martins Ryan | Chief Financial Officer | 02/05/2022 | 5,345 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2022 | 21,380 |
| Le-Nguyen Quoc | See Remarks | 02/05/2022 | 7,128 |
| Waisbourd Ram | See Remarks | 02/01/2022 | 13,510 |
| Waisbourd Ram | See Remarks | 02/01/2022 | 39,900 |
| PALEKAR ROHAN | Chief Executive Officer | 01/28/2022 | 15,350 |
| PALEKAR ROHAN | Chief Executive Officer | 01/27/2022 | 37,500 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/26/2022 | 180,019 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/25/2022 | 412,364 |
| Waisbourd Ram | See Remarks | 12/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 12/16/2021 | 80,360 |
| Waisbourd Ram | See Remarks | 11/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 11/16/2021 | 115,430 |
| Waisbourd Ram | See Remarks | 10/18/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 10/18/2021 | 122,430 |
| Waisbourd Ram | See Remarks | 09/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 09/16/2021 | 136,220 |
| Waisbourd Ram | See Remarks | 08/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 08/16/2021 | 127,960 |
| Waisbourd Ram | See Remarks | 07/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 07/16/2021 | 117,600 |
| PALEKAR ROHAN | Chief Executive Officer | 07/07/2021 | 85,350 |
| PALEKAR ROHAN | Chief Executive Officer | 07/08/2021 | 32,500 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 06/02/2021 | 415,530 |
| Grunberg Gregory | Director | 04/21/2021 | 23,460 |
| Waisbourd Ram | See Remarks | 03/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 03/16/2021 | 169,400 |
| Hayden Michael R | Director | 02/23/2021 | 172,236 |
| Waisbourd Ram | See Remarks | 02/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 02/16/2021 | 163,730 |
| Waisbourd Ram | See Remarks | 01/19/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 01/19/2021 | 148,120 |
| Waisbourd Ram | See Remarks | 12/16/2020 | 13,510 |
| Waisbourd Ram | See Remarks | 12/16/2020 | 189,280 |
| Le-Nguyen Quoc | See Remarks | 11/16/2020 | 14,144 |
| Le-Nguyen Quoc | See Remarks | 11/16/2020 | 127,844 |
| Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 13,510 |
| Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 191,730 |
| ORBIMED ADVISORS LLC | Director | 09/21/2020 | 7,700,000 |
| Naschitz Anat | Director | 09/21/2020 | 7,700,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 09/17/2020 | 36,400,000 |
| Longitude Capital Partners III, LLC | 10% Owner | 07/10/2020 | 2,999,975 |
| Grunberg Gregory | Director | 07/10/2020 | 2,999,975 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/08/2020 | 7,562,500 |
| Kariv Tomer | Director | 11/11/2019 | 4,000,000 |
| Naschitz Anat | Director | 11/11/2019 | 13,400,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 11/11/2019 | 24,000,000 |
| Grunberg Gregory | Director | 11/11/2019 | 9,200,000 |
| Hayden Michael R | Director | 11/11/2019 | 300,000 |
| Longitude Capital Partners III, LLC | 10% Owner | 11/11/2019 | 9,200,000 |
| ORBIMED ADVISORS LLC | Director | 11/11/2019 | 13,400,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN 89BIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12,766,948 | 3.06% | 11.82% | Other |
| BLACKROCK INC. | 5,454,196 | 0.00155% | 9.83% | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,888,434 | 2.47% | 81.43% | Growth At A Reasonable Price |
| HOLOCENE ADVISORS, LP | 3,490,628 | 0.15% | 56.12% | Growth At A Reasonable Price |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,125,000 | 0.07% | 83.99% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,377,710 | 0.00161% | 6.47% | Other |
| CANDRIAM S.C.A. | 280,000 | 0.02% | 27.27% | Other |
| UBS OCONNOR LLC | 79,075 | 0.06% | -20% | Value |
| ALPS ADVISORS INC | 52,456 | 0.00461% | -5.77% | Other |
| D. E. SHAW & CO., INC. | 13,957 | 0.00014% | -23.75% | Other |
CHANGE IN SHARES OUTSTANDING FOR 89BIO INC
STOCK BUYBACKS FOR 89BIO INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
5.85%
1Q
06/30/2023
9.01%
2Q
09/30/2022
71.00%
5Q
BUYBACK ANNOUNCEMENT(S) FOR 89BIO INC
LOADING...